The barriers and facilitators to satisfaction with botulinum neurotoxin treatment in people with cervical dystonia: a systematic review.

ABSTRACT:

Background

Cervical dystonia (CD) is an isolated, focal, idiopathic dystonia affecting the neck and upper back. CD is usually treated by botulinum neurotoxin (BoNT) injections into the dystonic muscles; however, about 20% of people will discontinue BoNT therapy. This systematic review aimed to determine the barriers to satisfaction and facilitators that could improve satisfaction with BoNT therapy for people with CD.

Methods

A database search for journal articles investigating satisfaction with BoNT treatment in CD identified seven qualitative studies and one randomised controlled trial. Results were grouped into "direct" and "indirect" barriers and facilitators.

Results

The most reported direct barrier to satisfaction with BoNT was treatment non-response, reported by

SUBMITTER: Boyce MJ 

PROVIDER: S-EPMC9349125 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature